Sort
82,697 grants matching “vaccine development”
HIV Vaccine Research and Development - NIAID DAIDS Vaccine Research Program
$15,730,991National Institute Of Allergy And Infectious Diseases · Y01 · FY2025 · AI
Animal Medicine Infrastructure Support - Animal Care
$15,705,915Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIG · FY2023 · AI
Institute for Clinical and Translational Research (UL1)
$15,683,386Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR
Animal Medicine Infrastructure Support - Animal Care
$15,543,641Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIG · FY2024 · AI
HVTN Laboratory Program
$15,461,760Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI
Institute for Clinical and Translational Research (UL1)
$15,450,860Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2008 · RR
Institute for Clinical and Translational Research (UL1)
$15,441,110Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV
$15,396,723Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
IMPAACT Leadership Group
$15,388,321Sharon A Nachman · Johns Hopkins University · UM1 · FY2022 · AI
Institute for Clinical and Translational Research (UL1)
$15,378,996Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
HIV Vaccine Research and Development - NIAID DAIDS Vaccine Research Program
$15,135,057National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
Center of Excellence for Influenza Research and Surveillance
$15,127,227Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2013 · AI
Development/production of universal influenza vaccines
$15,099,170Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2015 · AI
Therapeutics/Vaccine Teams
$15,067,360Charles Nicolette · Argos Therapeutics, Inc. · N01 · FY2010 · AI
Statistical and Data Management Center for the AIDS Clinical Trials Group
$15,061,511Michael David Hughes · Harvard School Of Public Health · UM1 · FY2012 · AI
Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines
$15,048,720Kiran Datta · Leidos Biomedical Research, Inc. · N01 · FY2024 · AI
Space Renovation for New Research Center for the Neglected Diseases of Poverty
$15,000,000Jeffrey S Akman · George Washington University · C06 · FY2010 · RR
Development/production of universal influenza vaccines
$14,987,979Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2020 · AI
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Lab
$14,980,054Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Production of a Broadly Neutralizing HIV Antibodies
$14,973,939Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2018 · AI
(CHAVI) Center for HIV/AIDS Vaccine Immunology
$14,900,000Duke University · U01 · FY2005 · AI
National Biocontainment Laboratories (NBLs) Operations Support
$14,856,806James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2015 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$14,844,618Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Penn State: ABSL-3 Facility Construction
$14,830,000Mary J. Kennett · Pennsylvania State University, The · C06 · FY2010 · RR
LOC-IMPAACT Leadership Group
$14,793,228Sharon A Nachman · Johns Hopkins University · UM1 · FY2014 · AI